Amphotericin B cholesteryl sulfate indications and usage: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) Created page with "__NOTOC__ {{mphotericin B cholesteryl sulfate}} {{CMG}}; {{AE}} {{AZ}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = AMPHOTEC (AMPHOTERICIN B) I..." |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AZ}} | {{CMG}}; {{AE}} {{AZ}} | ||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = AMPHOTEC (AMPHOTERICIN B) INJECTION, LIPID COMPLEX [INTERMUNE, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9b8ea543-1de8-472f-9666-34f99ca2f183 | publisher = | date = | accessdate = }}</ref> | ==Indications And Usage== | ||
AMPHOTEC is indicated for the treatment of invasive aspergillosis in patients where renal impairment or unacceptable toxicity precludes the use of amphotericin B deoxycholate in effective doses, and in patients with invasive aspergillosis where prior amphotericin B deoxycholate therapy has failed.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = AMPHOTEC (AMPHOTERICIN B) INJECTION, LIPID COMPLEX [INTERMUNE, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9b8ea543-1de8-472f-9666-34f99ca2f183 | publisher = | date = | accessdate = }}</ref> | |||
==References== | ==References== | ||
Revision as of 06:36, 10 January 2014
Template:Mphotericin B cholesteryl sulfate Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Indications And Usage
AMPHOTEC is indicated for the treatment of invasive aspergillosis in patients where renal impairment or unacceptable toxicity precludes the use of amphotericin B deoxycholate in effective doses, and in patients with invasive aspergillosis where prior amphotericin B deoxycholate therapy has failed.[1]
References
Adapted from the FDA Package Insert.